Beyond Medical Technologies Inc. (CSE: DOCT)
Canada
· Delayed Price · Currency is CAD 0.0300
0.00 (0.00%)
Nov 20, 2024, 9:30 AM EST
DOCT Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Revenue | - | - | - | - | 0.21 | - | Upgrade
|
| Cost of Revenue | - | - | - | - | 0.3 | 0.47 | Upgrade
|
| Gross Profit | - | - | - | - | -0.09 | -0.47 | Upgrade
|
| Selling, General & Admin | 0.48 | 0.51 | 0.67 | 1.24 | 1.71 | 2.5 | Upgrade
|
| Research & Development | - | - | - | - | 0.05 | 0.13 | Upgrade
|
| Operating Expenses | 0.48 | 0.51 | 0.8 | 1.44 | 1.91 | 2.75 | Upgrade
|
| Operating Income | -0.48 | -0.51 | -0.8 | -1.44 | -2 | -3.22 | Upgrade
|
| Interest Expense | - | - | - | - | -0.02 | - | Upgrade
|
| Interest & Investment Income | - | - | - | - | 0.01 | 0.05 | Upgrade
|
| Currency Exchange Gain (Loss) | 0 | -0 | 0 | -0 | 0 | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.03 | -0.03 | -0.04 | -0.43 | -0.05 | -0.06 | Upgrade
|
| EBT Excluding Unusual Items | -0.51 | -0.55 | -0.84 | -1.87 | -2.07 | -3.22 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | -0.21 | 0.36 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | -0.01 | -0 | Upgrade
|
| Asset Writedown | - | - | - | - | - | -2.51 | Upgrade
|
| Other Unusual Items | 0.07 | - | - | - | -4.24 | - | Upgrade
|
| Pretax Income | -0.43 | -0.55 | -0.84 | -1.87 | -6.52 | -5.37 | Upgrade
|
| Earnings From Continuing Operations | -0.43 | -0.55 | -0.84 | -1.87 | -6.52 | -5.37 | Upgrade
|
| Earnings From Discontinued Operations | -0.02 | -0.04 | -0.57 | -1.05 | - | - | Upgrade
|
| Net Income | -0.46 | -0.6 | -1.4 | -2.91 | -6.52 | -5.37 | Upgrade
|
| Net Income to Common | -0.46 | -0.6 | -1.4 | -2.91 | -6.52 | -5.37 | Upgrade
|
| Shares Outstanding (Basic) | 8 | 8 | 8 | 8 | 5 | 4 | Upgrade
|
| Shares Outstanding (Diluted) | 8 | 8 | 8 | 8 | 5 | 4 | Upgrade
|
| Shares Change (YoY) | - | - | 4.98% | 58.82% | 20.13% | 8.11% | Upgrade
|
| EPS (Basic) | -0.06 | -0.08 | -0.18 | -0.39 | -1.37 | -1.36 | Upgrade
|
| EPS (Diluted) | -0.06 | -0.08 | -0.18 | -0.39 | -1.37 | -1.36 | Upgrade
|
| Free Cash Flow | -0.23 | -0.53 | -0.95 | -1.4 | -2.07 | -3.58 | Upgrade
|
| Free Cash Flow Per Share | -0.03 | -0.07 | -0.12 | -0.19 | -0.44 | -0.91 | Upgrade
|
| Gross Margin | - | - | - | - | -44.54% | - | Upgrade
|
| Operating Margin | - | - | - | - | -960.44% | - | Upgrade
|
| Profit Margin | - | - | - | - | -3125.16% | - | Upgrade
|
| Free Cash Flow Margin | - | - | - | - | -991.16% | - | Upgrade
|
| EBITDA | - | - | -0.77 | -1.34 | -1.93 | -3.17 | Upgrade
|
| D&A For EBITDA | - | - | 0.03 | 0.1 | 0.07 | 0.05 | Upgrade
|
| EBIT | -0.48 | -0.51 | -0.8 | -1.44 | -2 | -3.22 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.